Overall survival defined as the date of documented complete remission (CR) until the dte of the latest follow-up or death by any cause 2 years [clinicaltrials_resource:2241820f1fce649aa822e35dad02138b]

Overall survival defined as the date of documented complete remission (CR) until the dte of the latest follow-up or death by any cause 2 years [clinicaltrials_resource:2241820f1fce649aa822e35dad02138b]

Standard of care
clinicaltrials resource [clinicaltrials_vocabulary:Resource]
Primary outcome [clinicaltrials_vocabulary:primary-outcome]
http://bio2rdf.org/clinicaltrials_resource:2241820f1fce649aa822e35dad02138b
Allogeneic HCT Using Nonmyeloablative Host Conditioning With TLI & ATG vs SOC in AML [clinicaltrials:NCT00568633]
clinicaltrials_vocabulary:primary outcome [clinicaltrials_vocabulary:clinicaltrials_vocabulary:primary-outcome]

Overall survival defined as the date of documented complete remission (CR) until the dte of the latest follow-up or death by any cause 2 years [clinicaltrials_resource:2241820f1fce649aa822e35dad02138b]

Standard of care
clinicaltrials resource [clinicaltrials_vocabulary:Resource]
Primary outcome [clinicaltrials_vocabulary:primary-outcome]
http://bio2rdf.org/clinicaltrials_resource:2241820f1fce649aa822e35dad02138b
Bio2RDF identifier
2241820f1fce649aa822e35dad02138b
Bio2RDF namespace
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:2241820f1fce649aa822e35dad02138b
measure [clinicaltrials_vocabulary:measure]
Overall survival defined as th ...... ollow-up or death by any cause
time frame [clinicaltrials_vocabulary:time-frame]
description
identifier
clinicaltrials_resource:2241820f1fce649aa822e35dad02138b
title
Overall survival defined as th ...... or death by any cause 2 years
@en
inDataset
type
label
Overall survival defined as th ...... 1820f1fce649aa822e35dad02138b]
@en